Miamo Multi-Peptide 20% Lifting Serum

Miamo is a specialized cosmeceutical brand founded in 2011 by Italian pharmacists Elena Sacco and Camillo Sacco. The brand represents a collaboration between Italian skin science tradition and American research laboratories, originally developed under the umbrella of Medspa S.r.l.

The Multi-Peptide 20% Lifting Serum is part of the 'Longevity Plus' line, designed to target expression lines using a high concentration of functional peptides. While the brand has global research roots, all products are primarily manufactured in Italy, maintaining high European pharmaceutical standards. In 2024, the brand received significant investment from the Italian private equity firm Alcedo, which now holds a majority stake in Medspa to accelerate its international expansion and R&D capabilities.